MyLigo, Inc
Healthcare
Summary
MyLigo uses advanced identity technology to accurately manage patient identities, reduce fraud, and improve healthcare outcomes.
Notable Achievements
- 3 MOUs, 2 pilots, active pursuits with VA and ARPA-H
The Business
MyLigo is a healthcare technology company that specializes in secure patient identity management. Their AI-powered platform helps healthcare organizations accurately identify patients, prevent fraud, and protect sensitive data. Ligo's solutions address the alarming rate of patient identification failures in the industry, which put both patients and providers at risk. The company's advanced technologies and operational principles enable healthcare systems to quickly and reliably verify patient identities, improving care coordination, reducing errors, and safeguarding sensitive information. Ligo's comprehensive platform includes tools for biometric identification, intelligent record matching, and real-time fraud detection. By automating and streamlining patient identity management, Ligo helps healthcare organizations improve operational efficiency, enhance the patient experience, and ensure regulatory compliance. With Ligo, hospitals, clinics, and other providers can focus on delivering high-quality care while minimizing the risks and costs associated with inaccurate patient data.
The Market
The global healthcare identity management market was valued at $16.1 billion in 2020 and is projected to reach $31.6 billion by 2027, growing at a CAGR of 10.2% from 2021 to 2027. Key drivers include the increasing need for accurate patient identification, rising healthcare data breaches, and growing regulatory mandates for healthcare data security. Ligo operates in the North American market, which accounted for the largest share of the global healthcare identity management market in 2020. The company faces competition from established vendors like Imprivata, NextGate, and Experian Health, as well as emerging startups. However, Ligo's AI-powered approach and focus on reducing healthcare fraud provide a unique value proposition in a rapidly evolving market.
Objective/Future (Use of funds)
Use of funds:
60k product/infrastructure
45k GTM/pilots
25k legal/IP (clean assignments + privacy/terms + 1 targeted filing),
20k ops/founder buffer
60k product/infrastructure
45k GTM/pilots
25k legal/IP (clean assignments + privacy/terms + 1 targeted filing),
20k ops/founder buffer
Growth Roadmap
MyLigo plans to continue expanding its customer base in the North American healthcare market, leveraging its robust technology platform and expertise in patient identity management. The company aims to secure additional Series A funding to scale its sales and marketing efforts, as well as invest in product development to enhance its AI and machine learning capabilities. Ligo also intends to pursue strategic partnerships with leading healthcare systems and technology providers to broaden its reach and integrate its solutions into broader care coordination and data management workflows.
© 2026 by AngelLinx. All rights reserved.
Jim StClair/MyLigo